leftymagazine

Uncompromising journalism for a just planet.

A column by Harrison Lockwood

News

Nairobi Biodiversity Summit Launches $10 Billion Fund to Tax Corporate Resource Extraction

Reuters reports that international delegates in Nairobi agreed to establish a “Nature Equity Fund” for conservation efforts in developing nations, financed through levies on pharmaceutical and biotech companies.

Harrison Lockwood, Lead Columnist on Systemic Justice & Climate Action·updated July 25, 2026

Nairobi Biodiversity Summit Launches $10 Billion Fund to Tax Corporate Resource Extraction

The summit’s reported $10 billion headline matters less as a victory lap than as a test of whether companies that profit from biological resources can finally be made to return some value to the places from which that wealth is extracted.

For years, the standard arrangement has been brutally efficient: biodiversity-rich countries carry the material costs of protecting ecosystems, while corporate supply chains and research pipelines capture the upside. A fund explicitly tied to levies on pharma and biotech begins to challenge that arrangement. Begins is the operative word.

A levy is not reparative finance by default

The Reuters report confirms an agreement to create the fund and identifies its intended financing mechanism. It does not, from the available detail, establish how the levies will be set, collected, governed, or distributed.

Those omissions are not bureaucratic footnotes. They are where power usually re-enters the room. A conservation fund can shift resources toward developing nations—or it can become another channel through which wealthy states, corporate actors and international institutions decide which landscapes deserve protection, on what terms, and at whose expense.

The core question is therefore not whether pharmaceutical and biotech companies should contribute. They should. It is whether the arrangement will recognise the people and countries maintaining living ecosystems as political actors with authority, rather than as recipients of conditional aid.

The corporate bill has finally entered the frame

There is a basic material logic here. Companies in pharmaceutical and biotechnology sectors can derive value from biological materials and knowledge; conservation in developing nations requires money. Linking those two facts through a levy is more honest than treating ecological protection as a charitable project funded by whoever feels generous at a summit.

It also punctures the familiar corporate script: private industry extracts value globally, then presents limited voluntary commitments as leadership. Levies replace some of that discretion with obligation. That is not radical. It is the minimum architecture required when profits depend on resources whose protection has been systematically underfunded.

The same week, the Financial Times reported that G20 finance ministers reached a preliminary agreement on a 2% minimum tax on the world’s wealthiest individuals to fund social welfare programmes. These are separate proposals, but they expose the same political fact: money exists. What has been missing is the willingness to compel those who accumulate the most from unequal systems to pay into public goods.

What deserves scrutiny now

The Nairobi agreement should be followed beyond its headline. Watch for the rules that determine who pays the levy, who controls the Nature Equity Fund, and what conservation efforts receive support. Watch, too, for whether “support” comes with conditions that preserve the leverage of rich governments and corporations over countries asked to protect globally valuable ecosystems.

We do not need another fund that converts ecological crisis into a branding opportunity for extractive industries. We need durable public finance that moves resources toward those carrying the burden of conservation—and governance that prevents the contributors from buying influence over the result.